Author： Dirk R.J. Kuypers
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.28, Iss.2, 2005-01, pp. : 153-181
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
A Benefit-Risk Assessment of Basiliximab in Renal Transplantation
By Boggi Ugo
Drug Safety, Vol. 27, Iss. 2, 2004-01 ,pp. :
Access to resources
Recommend
Benefit-Risk Assessment of Irinotecan in Advanced Colorectal Cancer
Drug Safety, Vol. 28, Iss. 5, 2005-01 ,pp. :
A Preliminary Benefit-Risk Assessment of Varenicline in Smoking Cessation
By Cahill Kate Stead Lindsay Lancaster Tim
Drug Safety, Vol. 32, Iss. 2, 2009-01 ,pp. :